This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

Germany, Heidelberg


The fund is located in Germany, Europe. The the headquarters of this VC is in Heidelberg.

In 2015, the fund's activity was at its peak. Deals in the range of 10 - 50 millions dollars are most common for this fund. The highest number of exits from this fund were in 2015. The fund generally invests in less than 2 deals every year. In comparison with other funds, CD-Venture makes 15 percentage points more than the average number of lead investments.

The overall number of key employee in the fund's team is 1.

The country of its establishment and the country of its most frequent investments coincides - Germany. However, start-ups from 2 other countries can be found in the fund's portfolio. Moreover, a start-up needs to be 6-10 years old to get investment from this fund. The fund has no an exact preference in the amount of founders of companies in its portfolio. If there are 4 or 5+ founders in the start-up, the probability of getting the investment is low. Among the most popular portfolio start-ups of the fund, are GenomeDx Biosciences, Exosome Diagnostics, Wellth. We can highlight the most popular investment areas for this fund, such as Biotechnology, Medical Device. In addition, there are 8 more industries where it has achieved success.

The fund typically invests in rounds with 7-8 participants. Along with CD-Venture, start-ups are often financed by Forbion Capital Partners, NGN Capital, Arcus Ventures as well as 2 other investors. The most common co-investors for the fund are Forbion Capital Partners, Yabeo Capital, Partnership Fund for New York City and also 10 different VCs. In subsequent rounds, the fund is usually supported by Shortcut Ventures GmbH, NGN Capital, Forbion Capital Partners, out of 3 investors from our database.

Fund Activity


Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name:; User name format in descending order of probability: first last, first, first last_initial, last first_initial, last

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]


Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

1.7 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.55 out of 1

Funds Investing in Previous

Forbion Capital Partners, NGN Capital, Arcus Ventures

Funds Investing in Following

Shortcut Ventures GmbH, NGN Capital, Forbion Capital Partners

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: